The TriggerHappy Trial (Triggerhappy)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04568993 |
Recruitment Status :
Active, not recruiting
First Posted : September 29, 2020
Last Update Posted : January 11, 2023
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Trigger Finger Trigger Thumb Minimally Invasive Surgery | Procedure: Proximal phalangeal level Drug: Volar to the MCP-joint | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 100 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Intervention Model Description: | Prospective randomized controlled trial |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | Patient-reported Outcome After Corticoid Injection for Triggerfinger- a Randomized Controlled Study Between Two Injection Procedures and Between Corticoid Injection and Percutaneous Release |
Actual Study Start Date : | October 1, 2020 |
Estimated Primary Completion Date : | April 1, 2024 |
Estimated Study Completion Date : | December 1, 2024 |
Arm | Intervention/treatment |
---|---|
Experimental: proximal phalangeal level
injection in the the tendon sheet over proximal phalanx of finger
|
Procedure: Proximal phalangeal level
Injection of methyl prednisone and lidocaine in the tendon sheet at the level of the proximal phalanx |
Active Comparator: volar MCP level
injection above the A1 pulley volar to the MCP joint
|
Drug: Volar to the MCP-joint
Injection of methyl prednisone and lidocaine in the tendon sheet volar to the MCP-joint |
- Pain after injection [ Time Frame: Four weeks ]Visual analouge scale (VAS), range 0-10, where 0 indicates "no pain" and 10 "maximum pain"
- Impairment of finger motion [ Time Frame: Four weeks ]Visual analouge scale (VAS), range 0-10, where 0 indicates "no impairment" and 10 "maximum impairment"
- Triggering [ Time Frame: Four weeks ]Visual analouge scale (VAS), range 0-10, where 0 indicates "no trigger phenomenon" and 10 "Trigger phenomenon all the time/ locked finger"
- Quick-DASH [ Time Frame: Four weeks ]generic handquestionaire, 11 items, 0 means normal hand function, 100 most impaired function
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:•
- Triggering of one or more fingers and/or impaired active finger motion and/or pain during active finger motion
- Localized tenderness volar to the MCP joint of the affected finger
- The patient seeks treatment
Exclusion Criteria:
- Previous treatment for triggerfinger in the finger to be treated
- Impaired function of finger due to previous trauma/infection or other condition
- Suspicion of other cause than triggeriinger/tendovaginitis
- Patient not able to follow instructions
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04568993
Sweden | |
Alingsås Lasarett/ District Hospital | |
Alingsås, Sweden |
Responsible Party: | Joakim Stromberg, Senior consultant surgeon, MD, PhD, Sahlgrenska University Hospital, Sweden |
ClinicalTrials.gov Identifier: | NCT04568993 |
Other Study ID Numbers: |
The TriggerHappy Trial |
First Posted: | September 29, 2020 Key Record Dates |
Last Update Posted: | January 11, 2023 |
Last Verified: | January 2023 |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Trigger Finger Disorder Tendon Entrapment Tendinopathy Muscular Diseases Musculoskeletal Diseases |